This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H1N1 Neuraminidase (NA)
Product Overview
BioVenic's Recombinant Influenza A H1N1 Neuraminidase (NA) is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 51.9 kDa. The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
H1N1 flu, commonly known as swine flu, is a variant of the influenza A virus. Swine influenza can result from several influenza A subtypes, such as H1N1, H1N2, H2N3, H3N1, and H3N2. The primary surface glycoproteins of the influenza virus, hemagglutinin (HA) and neuraminidase (NA), are crucial for the virus's infectivity and are the primary targets for neutralizing antibodies.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.
References
- McAuley, Julie L et al. "Influenza Virus Neuraminidase Structure and Functions." Frontiers in microbiology vol. 10 39. 29 Jan. 2019.